BAG-1 and Bcl-2 in IL-2 Signaling

References

• Yonish-Rouach E., Resnitzky D., Lotem J., Sachs L., Kimchi A., Oren M. Wil-type p53 induces apop-tosis of myeloid leukemic cells that is inhibited by interleukin 6. Nature 1991; 352: 345–347
   PubMed Web of Science ®Google Scholar
• Shaw P., Bovey R., Tardy S., Sahli R., Sordat B., Costa J. Induction of apoptosis by wild type p53 in a human colon tumor derived cell line. Proc. Natl. Acad. Sci. USA 1992; 89: 4495–4499
   PubMed Web of Science ®Google Scholar
• Oltari Z., Milliman C., Korsmeyer S.J. Bcl-2 heterodimers in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619
   PubMed Web of Science ®Google Scholar
• Yang E., Zha J., Jockel J., Boise L.H., Thompson C.B., Korsmeyer S.J. Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces Bax and promotes cell death. Cell 1995; 80: 285–291
   PubMed Web of Science ®Google Scholar
• Boise L.H., Gonzaaltz-García M., Postema C.E., Ding L., Lindsten T., Turka L.A., Mao X., Nunez G., Thompson C.B. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 1–20
   PubMed Web of Science ®Google Scholar
• White E., Cipriani R., Sabbatini P., Denton A. Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins. J. Virol. 1991; 65: 2968–2978
   PubMed Web of Science ®Google Scholar
• Rao L., Debbas M., Sabbatini P., Hockenbery D., Korsmeyer S., White E. The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc. Natl. Acad. Sci. USA 1992; 89: 7742–7746
   PubMed Web of Science ®Google Scholar
• Tsujimoto Y., Cossman J., Jaffe E., Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228: 1440–1443
   PubMed Web of Science ®Google Scholar
• Reed J.C. Bcl-2 and the regulation of programmed cell death. J. Cell Biol. 1994; 124: 1–6
   PubMed Web of Science ®Google Scholar
• Lotem J., Sachs L. Regulation by bcl-2, c-myc and p53 of susceptibility to induction of apoptosis by heat shock and cancer chemotherapy compounds in differentiation competent and defective myeloid leukemic cells. Cell Growth Differ. 1993; 441–417
   Google Scholar
• Gooding L.R., Elmore L.W., Tollefson A.E., Brody H.A., Wold W.S. A 14,700 MW protein from the E3 region of adenovirus inhibite cytolysis by tumor necrosis factor. Cell 1988; 53: 341–346
   PubMed Web of Science ®Google Scholar
• Chou J., Roizman B. The γ1 34.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthersis characteristic of programmed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 1992; 89: 3266–3270
   PubMed Web of Science ®Google Scholar
• Torigoe T., Millan J.A., Takayama S., Taichman R., Miyasita T., Reed J.C. Bcl-2 inhibits T-cell-mediated cytolysis of a leukemia cell line. Cancer Res. 1994; 54: 4851–4854
   PubMed Web of Science ®Google Scholar
• McDonnell T.J., Deane N., Piatt F.M., Numez G., Jaeger V., McKearn J.P., Korsmeyer S.J. bcl-2 immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell 1989; 57: 79–88
   PubMed Web of Science ®Google Scholar
• Cleary M.L., Smith S.D., Sklar J. Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/ immunoglobulin transcript resulting from the t(14;18) translocation. Cell 1986; 47: 19–28
   PubMed Web of Science ®Google Scholar
• Adachi M., Tefferi A., Greipp P.R., Kipps T.J., Tsujimoto Y. Preferential linkage of BCL-2 to immunoglobulin light chain gene in chronic lymphocytic leukemia. J. Exp. Med. 1990; 171: 559–564
   PubMed Web of Science ®Google Scholar
• Hanada M., Delia D., Aiello A., Stadtmauer E., Reed J.C. Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 1993; 82: 1820–1828
   PubMed Web of Science ®Google Scholar
• Takayama S., Sato T., Krajewski S., Kochel K., Irie S., Millan J.A., Reed J.C. Cloning and functional analysis of BAG-1: a novel Bcl-2-binding protein with anti-cell death activity. Cell 1995; 80: 279–284
   PubMed Web of Science ®Google Scholar
• Cazals-Hatem D., Louie D., Tanaka S., Reed J.C. Molecular cloning and DNA sequence analysis of cDNA encoding chicken homolog of the Bcl-2 oncoprotein. Biochim. Biophys. Acta. 1992; 1132: 109–113
   PubMed Web of Science ®Google Scholar
• Chen-Levy S., Cleary M.L. Membrane topology of the Bcl-2 proto-oncogenic protein demonstrated in vitro. J Biol. Chem. 1990; 265: 4929–4933
   PubMed Web of Science ®Google Scholar
• Tanaka S., Saito K., Reed J.C. Structure-function analysis of the apoptosis-suppressing Bcl-2 oncoprotein: substitution of a heterologous transmembrane domain restores function to truncated Bcl-2 proteins. J. Biol. Chem. 1993; 268: 10920–10926
   PubMed Web of Science ®Google Scholar
• Henderson S., Huen D., Rowe M., Dawson C., Johnson G., Rickinson A. Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. Proc. Natl. Acad. Sci. USA 1993; 90: 8479–8483
   PubMed Web of Science ®Google Scholar
• Sato T., Hanada M., Bodrug S., Irie S., Iwana N., Boise L.H., Thompson C.B., Golemis E., Fong L., Wang H.-G., Reed J.C. Interaction among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc. Natl. Acad. Sci. USA 1994; 91: 9238–9242
   PubMed Web of Science ®Google Scholar
• Zha H., Aimé-Sempé C., Sato T., Reed J.C. Proapoptotic Protein Bax Heterodimerizes with Bcl-2 and Homodimerizes with Bax via a Novel Domain (BH3) Distinct from BH1 and BH2. J. Biol. Chem. 1996; 271: 7440–7444
   PubMed Web of Science ®Google Scholar
• Rechsteiner M. Natural substrates of the ubiquitin proteolytic pathway. Cell 1991; 66: 615–618
   PubMed Web of Science ®Google Scholar
• Hockenbery D., Nunez G., Milliman C., Schreiber R.D., Korsmeyer S.J. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed Cell death. Nature (Lond.) 1990; 348: 334–336
   PubMed Web of Science ®Google Scholar
• Monaghan P., Robertson D., Amos A.S., Dyer J.S., Mason D.Y., Greaves M.F. Ultrastructural localization of Bcl-2 protein. J. Histochem. Cytochem. 1992; 40: 1819–1825
   PubMed Web of Science ®Google Scholar
• Krajewski S., Tanaka S., Takayama S., Schibler M.J., Fenton W., Reed J.C. Investigations of the subcellular distribution of the BCL-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 1993; 53: 4701–4714
   PubMed Web of Science ®Google Scholar
• Zhong L.-T., Sarafian T., Kane D.J., Charles C., Man S.P., Edwards R.H., Bredessen D.E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA 1993; 90: 4533–4537
   PubMed Web of Science ®Google Scholar
• Hennet T., Bertoni G., Richter C., Peterhans E. Expression of Bcl-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity. Cancer Res. 1993; 53: 1456–1460
   PubMed Web of Science ®Google Scholar
• Aagaard K.M., Jelinek D.F. Differential activation of a calcium-dependent endonuclease in human B-lymphocytes. J. Immunol 1995; 155: 3297–3307
   PubMed Web of Science ®Google Scholar
• Linette G.P., Li Y., Roth K., Korsmeyer S.J. Cross talk between cell death and cell cycle progression: Bcl-2 regulates NFAT-mediated activation. Proc. Natl. Acad. Sci. USA 1996; 93: 9545–9552
   PubMed Web of Science ®Google Scholar
• Shibasaki F., Kondo E., Akagi T., McKeon F. Suppression of signalling through transcription factor NF-AT by interactions between calcineurin and Bcl-2. Nature 1997; 386: 728–731
   PubMedGoogle Scholar
• Shibasaki F., McKeon F. Calcineurin functions in Ca2+-activated cell death in mammalian cells. J. Cell Biol. 1995; 131: 735–743
   PubMed Web of Science ®Google Scholar
• Wang H.-G., Takayama S., Rapp U.R., Reed J.C. Bcl-2 interracting protein, BAG-1, binds to and activates the kinase Raf-1. Proc. Natl. Acad. Sci. USA 1996; 93: 7063–7068
   PubMed Web of Science ®Google Scholar
• Wang H.G., Miyashita T., Takayama S., Sato T., Torigoe T., Krajewski S., Tanaka S., Hovey L., Troppmair J., Rapp U.R., Reed J.C. Apoptosis regulation by interaction of Bcl-2 protein and Raf-1 kinase. Oncogene 1994; 9: 2751–2756
   PubMed Web of Science ®Google Scholar
• Wang H.-G., Rapp U.R., Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 1996; 87: 629–638
   PubMed Web of Science ®Google Scholar
• Zah J., Harada H., Yang E., Jockel J., Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-XL. Cell 1996; 87: 619–628
   PubMed Web of Science ®Google Scholar
• Takayama S., Bimston D.N., Matsuzawa S., Freeman B.C., Aime-Sempe C., Xie Z., Morimoto R.I., Reed J.C. BAG-1 modulates the chaperone activity of Hsp70/Hsc70. EMBO J. 1997, in press
   PubMed Web of Science ®Google Scholar
• Bardelli A., Longati P., Albero D., Goruppi S., Schneider C., Ponzetto C., Comoglio P.M. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 1996; 15: 6205–6212
   PubMed Web of Science ®Google Scholar
• Takeshita T., Asao H., Ohtani K., Ishii N., Kumaki S., Tanaka N., Munakata H., Nakamura M., Sugamura K. Cloning of the y chain of the human IL-2 receptor. Science 1992; 257: 379–382
   PubMed Web of Science ®Google Scholar
• Hatakeyama M., Mori H., Doi T., Taniguchi T. A restricted cytoplasmic region of IL-2 receptor β chain is essential for growth signal transduction but not for ligand binding and internalization. Cell 1989; 59: 837–845
   PubMed Web of Science ®Google Scholar
• Shibuya H., Yoneyama M., Ninomiya-Tsuji J., Matsumoto K., Taniguchi T. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell 1992; 70: 57–67
   PubMed Web of Science ®Google Scholar
• Reed J.C., Tsujimoto Y., Alpers J.D., Croce C.M., Nowell P.C. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation. Science 1987; 236: 1295–1299
   PubMed Web of Science ®Google Scholar
• Deng G., Podack E.R. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of the protooncogene bcl-2. Proc. Natl. Acad. Sci. USA 1993; 90: 2189–2193
   PubMed Web of Science ®Google Scholar
• Miyazaki T., Liu Z.-J., Kawahara A., Minami Y., Yamada K., Tsujimoto Y., Barsoumian E.L., Perlmutter R.M., Taniguchi T. Three distinct IL-2 signaling pathways mediated by bcl-2, c-myc, and lck cooperate in hematopoietic cell proliferation. Cell 1995; 81: 223–231
   PubMed Web of Science ®Google Scholar
• Adachi M., Sekiya M., Torigoe T., Takayama S., Reed J.C., Miyazaki T., Minami Y., Taniguchi T., Imai K. Interleukin-2 (IL-2) upregulates BAG-1 gene expression through serine-rich region within IL-2 receptor βc chain. Blood 1996; 88: 4118–4123
   PubMed Web of Science ®Google Scholar
• Minami Y., Nakagawa Y., Kawahara A., Miyazaki T., Sada K., Yamamura H., Taniguchi T. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway. Immunity 1995; 2: 89–100
   PubMed Web of Science ®Google Scholar
• Miyazaki T., Kawahara A., Fujii H., Nakagawa Y., Minami Y., Liu Z.-J., Oishi I., Silvennoinen O., Witchuhn B.A., Ihle J.N., Taniguchi T. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 1994; 266: 1045–1047
   PubMed Web of Science ®Google Scholar
• Kawahara A., Minami Y., Miyazaki T., Ihle J.N., Taniguchi T. Critical role of the interleukin 2 (IL-2) receptor γ-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene induction. Proc. Natl. Acad. Sci. USA 1995; 92: 8724–8728
   PubMed Web of Science ®Google Scholar
• Hartley K.O., Gell D., Smith G.C.M., Zhang H., Divecha N., Connelly M.A., Admon A., Lees-Miller S.P., Anderson C.W., Jackson S.P. DNA-dependent kinase catalytic subunit: a relative of phosphatidyiinositol 3-kinase and the ataxia telengiectasia gene product. Cell 1995; 82: 849–856
   PubMed Web of Science ®Google Scholar
• Miyajima M., Kitamura T., Harada N., Yokota T., Arai K. Cytokine receptors and signal transduction. Annu. Rev. Immunol 1992; 10: 295–331
   PubMed Web of Science ®Google Scholar
• Miyajima M., Nui A. L.-F., Ogorochi T., Sakamaki K. Receptor for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 1993; 82: 1960–1974
   PubMed Web of Science ®Google Scholar
• Kinoshita T., Yokota T., Arai K., Miyajima A. Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO J. 1995; 14: 266–275
   PubMed Web of Science ®Google Scholar
• Miura O., Nakamura N., Quelle F.W., Witthuhn B.A., Ihle J.N., Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoiein receptor in vivo. Blood 1994; 84: 1501–1507
   PubMed Web of Science ®Google Scholar
• Zhuang H., Patel S.V., He T., Sonsteby S.K., Niu Z., Wojchowski D.M. Inhibition of erythropoietin-induced mitogenesis by a kinase-deficient form of Jak2. J. Biol. Chem. 1994; 269: 21411–21414
   PubMed Web of Science ®Google Scholar
• Zhuang H., Niu Z., He T.-C, Patel S.V., Wojchowski D.M. Erythropoietin-dependent inhibition of apopto-sis is supported by carboxyl-truncated receptor forms and blocked by dominant-negative forms of Jak2. J. Biol. Chem. 1995; 270: 14500–14504
   PubMed Web of Science ®Google Scholar